NMRA- Neumora Therapeutics, Inc.

Name: Neumora Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neumora Therapeutics, Inc. (NMRA) has 12 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. NMRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Arch Venture Partners X, LLC	6.05M	$11.07M	-
10%	Burow Kristina	6.05M	$11.07M	-
10%	Arch Venture Partners Xii, LLC	6.05M	$11.07M	-
Other	Berns Paul L	1.65M	$3.02M	-
Pres	Pinto Joshua	1.20M	$2.20M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 7, 2023	Arch Venture Partners Xii, LLC63	10% Owner	Buy	95,694	$11.49	$1,099,944.70	+0.8%	+30.9%	+9.6%
Sep 29, 2023	Burow Kristina68	Director, 10% Owner	Buy	76,511	$13.68	$1,046,848.16	+0.7%	+21.5%	-8.4%
Sep 29, 2023	Arch Venture Partners Xii, LLC63	10% Owner	Buy	76,511	$13.68	$1,046,848.16	+0.7%	+21.5%	-8.4%
Sep 27, 2023	Burow Kristina68	Director, 10% Owner	Buy	58,504	$11.97	$700,464.24	+0.8%	+48.1%	+10.7%
Sep 27, 2023	Arch Venture Partners Xii, LLC63	10% Owner	Buy	58,504	$11.97	$700,464.24	+0.8%	+48.1%	+10.7%
Sep 25, 2023	Arch Venture Partners Xii, LLC63	10% Owner	Buy	100,740	$11.19	$1,127,063.95	+0.9%	+53.6%	+8.6%
Sep 25, 2023	Burow Kristina68	Director, 10% Owner	Buy	100,740	$11.19	$1,127,063.95	+0.9%	+53.6%	+8.6%
Sep 19, 2023	Arch Venture Partners X, LLC	10% Owner	Buy	1,500,000	$17.00	$25,500,000.00	+70.6%	+22.6%	+1.9%
Sep 19, 2023	Arch Venture Partners X, LLC	10% Owner	Buy	1,500,000	$17.00	$25,500,000.00	+70.6%	+22.6%	+1.9%
Sep 19, 2023	Burow Kristina68	Director, 10% Owner	Buy	1,500,000	$17.00	$25,500,000.00	+70.6%	+22.6%	+1.9%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC